New investment in the health sector: Pharmaceutical unit in Kozani
A significant investment in the pharmaceutical industry was recently announced by the company Rontis, which is set to establish a new production unit in the Kozani region. This move strengthens the company's presence in Greece and is expected to contribute positively to the local economy.
The new unit will focus on the production of specialized pharmaceutical products, following the most modern international quality standards. The choice of Kozani for the factory's installation is not accidental, as the region is in a phase of transformation, seeking new development outlets following de-lignitization.
This investment is expected to create dozens of new jobs for local residents, offering employment opportunities for scientists, technicians, and specialized personnel. At the same time, the operation of the factory will boost the company's export activity, promoting Greek health products in international markets.
The management of Rontis emphasized that the new facility is part of a broader strategic plan for growth and innovation. The company systematically invests in research and technology, aiming to improve the quality of life for patients through its pharmaceutical solutions.
The commencement of the unit's operation serves as an optimistic message for the Greek industry. Strengthening the country's production base in critical sectors, such as health, is considered decisive for future economic stability and regional development.